Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England …

…, R Simmons, S Cottrell, R Roberts, M O'Doherty… - bmj, 2021 - bmj.com
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the …

… on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium

…, K Kuulasmaa, T Laatikainen, MG O'Doherty… - bmj, 2015 - bmj.com
Objective To investigate the impact of smoking and smoking cessation on cardiovascular
mortality, acute coronary events, and stroke events in people aged 60 and older, and to …

Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and …

…, R Simmons, S Cottrell, R Roberts, M O'Doherty… - MedRxiv, 2021 - medrxiv.org
Objectives To estimate the real-world effectiveness of the Pfizer/BioNTech BNT162b2 vaccine
and Astrazeneca ChAdOx1 vaccine against Confirmed COVID-19, hospitalisations and …

[HTML][HTML] Excess all-cause mortality during the COVID-19 pandemic in Europe–preliminary pooled estimates from the EuroMOMO network, March to April 2020

…, M Sinnathamby, N Andrews, M O'Doherty… - …, 2020 - eurosurveillance.org
A remarkable excess mortality has coincided with the COVID-19 pandemic in Europe. We
present preliminary pooled estimates of all-cause mortality for 24 European countries/federal …

A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH–AARP Diet and Health Study

MG O'Doherty, ND Freedman, AR Hollenbeck… - Gut, 2012 - gut.bmj.com
Objective The incidence of oesophageal adenocarcinoma (EAC) has increased rapidly over
the past 40 years and accumulating evidence suggests that obesity, as measured by body …

Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries

…, J Igland, T Jørgensen, Y Nikitin, MG O'Doherty… - Heart, 2014 - heart.bmj.com
Objective To assess the seasonality of cardiovascular risk factors (CVRF) in a large set of
population-based studies. Methods Cross-sectional data from 24 population-based studies …

[HTML][HTML] … of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium

…, H Freisling, B Bueno-de-Mesquita, MG O'Doherty… - BMC medicine, 2016 - Springer
Background Smoking is the most important individual risk factor for many cancer sites but its
association with breast and prostate cancer is not entirely clear. Rate advancement periods (…

[HTML][HTML] Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

…, M Sinnathamby, N Andrews, MG O'Doherty… - …, 2021 - eurosurveillance.org
The European monitoring of excess mortality for public health action (EuroMOMO) network
monitors weekly excess all-cause mortality in 27 European countries or subnational areas. …

[HTML][HTML] Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of …

…, M Arnold, I Soerjomataram, MG O'Doherty… - British journal of …, 2017 - nature.com
Background: We evaluated the associations of anthropometric indicators of general obesity (body
mass index, BMI), an established risk factor of various cancer, and body fat distribution …

[HTML][HTML] … and jointly, on life expectancy with and without cardiovascular disease: results from the Consortium on Health and Ageing Network of Cohorts in Europe and …

MG O'Doherty, K Cairns, V O'Neill, F Lamrock… - European journal of …, 2016 - Springer
Seldom have studies taken account of changes in lifestyle habits in the elderly, or investigated
their impact on disease-free life expectancy (LE) and LE with cardiovascular disease (…